| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/18/2004 | US6736154 Pressure vessel systems and methods for dispensing liquid chemical compositions |
| 05/18/2004 | CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/18/2004 | CA2343715C New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/18/2004 | CA2052822C Methods and reagents for identifying bacteria |
| 05/18/2004 | CA2012321C Spin filter for removing substantially cell-free culture medium from suspension cell culture system |
| 05/13/2004 | WO2004040315A1 Process for producing labeled nucleic acid or protein |
| 05/13/2004 | WO2004040019A1 Method of amplifying nucleic acid |
| 05/13/2004 | WO2004040018A2 Qualitative differential screening for the detection of rna splice sites |
| 05/13/2004 | WO2004039999A2 Essential dna enclosed proteins of drosphophilia melanogaster |
| 05/13/2004 | WO2004039995A1 Mutagenesis methods using ribavirin and/or rna replicases |
| 05/13/2004 | WO2004039990A2 Cells for determining the presence of a molecule that activates signal transduction activity of a cell surface protein |
| 05/13/2004 | WO2004039988A1 Ppr peptide sequences capable of restoring male fertility of plants bearing a male sterility-inducing cytoplasm |
| 05/13/2004 | WO2004039987A2 Methods for increasing the efficiency of homologous recombination in cells of vascular plants |
| 05/13/2004 | WO2004039986A1 Cot102 insecticidal cotton |
| 05/13/2004 | WO2004039985A2 Selective expression in filamentous fungi |
| 05/13/2004 | WO2004039983A2 Method for inserting a nucleic acid of interest into a prokaryotic or eukaryotic cell by homologous recombination |
| 05/13/2004 | WO2004039982A1 Enzymes dephosphorylating actin depolymerizing factor cofilin and genes thereof |
| 05/13/2004 | WO2004039981A1 Membrane protein originating in mast cells |
| 05/13/2004 | WO2004039980A1 Agents modulating mal activity |
| 05/13/2004 | WO2004039979A1 Means and methods for diagnosing and treating idiopathic generalized epilepsy (ige) |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039976A1 Novel glycosyltransferase, nucleic acid encoding the same and method of detecting cancer tissue using the nculeic acid |
| 05/13/2004 | WO2004039975A1 Nucleic acids isolated from neuroblastoma at stage 4s |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039969A1 Novel cellulase tolerant to surfactants |
| 05/13/2004 | WO2004039967A1 Immortalized natural killer cell line |
| 05/13/2004 | WO2004039957A2 Inhibition of gene expression using rna interfering agents |
| 05/13/2004 | WO2004039953A2 Array oligomer synthesis and use. |
| 05/13/2004 | WO2004039951A2 Il-1 receptor based antagonists and methods of making and using |
| 05/13/2004 | WO2004039946A2 Methods for increasing total oil levels in plants |
| 05/13/2004 | WO2004039944A2 Tri-block polymers for nanosphere-based drug or gene delivery |
| 05/13/2004 | WO2004039941A2 METHODS OF SCREENING FOR TRPM4b MODULATORS |
| 05/13/2004 | WO2004039846A1 Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof |
| 05/13/2004 | WO2004039842A2 Humanized tissue factor antibodies |
| 05/13/2004 | WO2004039841A2 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | WO2004039840A1 Chimeric cytoplasmic signalling molecules |
| 05/13/2004 | WO2004039839A2 Modified voltage-gated calcium channels |
| 05/13/2004 | WO2004039836A1 Soluble truncated polypeptides of the nogo-a protein |
| 05/13/2004 | WO2004039834A2 Recombinant protein variants |
| 05/13/2004 | WO2004039825A2 Method for the synthesis of a bifunctional complex |
| 05/13/2004 | WO2004039412A2 Compositions for cancer treatment |
| 05/13/2004 | WO2004039407A1 Apoptosis inducer |
| 05/13/2004 | WO2004039405A1 Use of sglt homolog |
| 05/13/2004 | WO2004039396A1 Drug containing angiotensin convertase |
| 05/13/2004 | WO2004039394A1 Novel composition and methods for the treatment of immune related diseases |
| 05/13/2004 | WO2004039311A2 Human vps4a and vps4b functions in viral budding |
| 05/13/2004 | WO2004039309A2 Dc-sign isoforms, related compositions and methods for their use in disease therapy |
| 05/13/2004 | WO2004039234A2 Humanized antibodies against the venezuelan equine encephalitis virus |
| 05/13/2004 | WO2004039149A1 Nonhuman model animal suffering from guillain-barre syndrome and/or fisher syndrome |
| 05/13/2004 | WO2004033495A3 Regulation of human pde6b |
| 05/13/2004 | WO2004029223A3 Polynucleotide synthesis and labeling by kinetic sampling ligation |
| 05/13/2004 | WO2004027072A3 Method for making recombinant proteins |
| 05/13/2004 | WO2004022102A3 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 05/13/2004 | WO2004020602A3 Terminal phosphate blocked nucleoside polyphosphates |
| 05/13/2004 | WO2004019036A3 Method for identifying substances |
| 05/13/2004 | WO2004015114A3 Heterologous expression system comprising a b. subtilis promoter |
| 05/13/2004 | WO2004014302A3 Mechanisms of myoblast transfer in treating heart failure |
| 05/13/2004 | WO2004013274A3 Ghrelin binding nucleic acids |
| 05/13/2004 | WO2004009792A3 Transposon-based vectors and methods of nucleic acid integration |
| 05/13/2004 | WO2004000006A3 Method of transforming soybean |
| 05/13/2004 | WO2003105778A3 Phosphatidylinositol-4-phosphate 5-kinase, type ii beta inhibitors for inhibiting angiogenesis |
| 05/13/2004 | WO2003104406A3 Improvements for combinatorial oligonucleotide pcr |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003097835A3 Pharmaceutical compositions for the treatment of cancer |
| 05/13/2004 | WO2003097661A3 Antiviral phosphorothioate oligonucleotides |
| 05/13/2004 | WO2003093453A3 Bacillus licheniformis mutant host cell |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003072586B1 Methods of producing phosphitylated compounds |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003068163A3 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 05/13/2004 | WO2003066891A3 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle |
| 05/13/2004 | WO2003064651A3 Regulation of human membrane-type serine protease |
| 05/13/2004 | WO2003057892B1 Viruses with enhanced lytic potency |
| 05/13/2004 | WO2003053921A9 Mutant proteinase inhibitors and uses thereof |
| 05/13/2004 | WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003049762A3 Immunisation against chlamydia trachomatis |
| 05/13/2004 | WO2003040293A3 Genes coding for stress resistance and tolerance proteins |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003033657A3 Antisense antiviral agent and method for treating ssrna viral infection |
| 05/13/2004 | WO2003029471A8 Muteins of apolipoprotein d |
| 05/13/2004 | WO2003020935A8 Control of plant flowering time by regulating the expression of phytochrome c |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003014381A9 System for detecting protease |
| 05/13/2004 | WO2003006950B1 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2003003014A9 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 05/13/2004 | WO2002061041A9 Solubility reporter gene constructs |
| 05/13/2004 | WO2002057301A3 Gene silencing suppressor |
| 05/13/2004 | WO2002048377A8 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof |
| 05/13/2004 | WO2002038171A9 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/13/2004 | WO2002016440A9 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 05/13/2004 | WO2002012273A9 Herbicide target genes and methods |
| 05/13/2004 | WO2000069885A8 Secreted proteins and uses thereof |
| 05/13/2004 | US20040093649 Assay for the detection of selectable marker expression in plants |
| 05/13/2004 | US20040093647 Propagating genetically engineered potato and/or tomato comprising DNA sequences coding glutamate dehydrogenase and having enhanced accumulation of serine, threonine, alanine, histidine, asparagine, aspartic and glutamic acids |
| 05/13/2004 | US20040093646 Production of lysosomal enzymes in plants by transient expression |
| 05/13/2004 | US20040093645 Transgenic plant production |